HGYN同业对比
HGYN 与SIC 2821 行业的逐项对比:市值、估值、增长、盈利能力、质量与总回报,以及在同业组内的排名。所有数值均由引擎从 SEC 申报与延迟行情计算,排名仅为组内排序位置 —— 描述性数据,非投资建议。
完整同业对比
同业组:同 SIC 行业分类 | 公司 | 市值 | 市盈率(TTM) | 市净率 | 市销率 | 营收同比增长 | 净利同比增长 | 息税前利润率 | 净资产收益率 | 投入资本回报率 | 皮氏 F 值 | 一年总回报 | 股息率 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HGYN本股 | — | — | — | — | 241.1%#1 | 257.1%#2 | 21.1%#1 | — | 37.1%#1 | — | — | — |
| DOW | $21.8B#1 | — | 1.4x#5 | 0.5x#2 | -7.0%#9 | 898.1%#1 | 11.4%#3 | 30.4%#1 | 16.7%#2 | 4#7 | — | 6.8%#1 |
| ALB | $13.9B#2 | — | 1.4x#4 | 2.7x#5 | -4.4%#6 | 56.7%#3 | -7.1%#8 | -5.2%#7 | -2.4%#6 | 6#1 | — | 1.4%#5 |
| EMN | $8.0B#3 | 18.2x#1 | 1.3x#2 | 0.9x#3 | -6.7%#8 | -47.6%#11 | 17.5%#2 | 7.8%#3 | 11.9%#3 | 5#5 | — | 4.8%#2 |
| HXL | $7.8B#4 | 42.2x#3 | 6.0x#7 | 4.1x#7 | -0.5%#4 | -17.2%#10 | 9.1%#4 | 8.4%#2 | 6.3%#4 | 5#5 | — | 0.7%#6 |
| AVNT | $3.3B#5 | 21.1x#2 | 1.4x#3 | 1.0x#4 | 0.6%#2 | -51.7%#12 | 6.2%#5 | 3.4%#5 | 3.7%#5 | 4#7 | — | 3.0%#4 |
| ROG | $2.2B#6 | — | 1.8x#6 | 2.7x#6 | -2.3%#5 | -336.8%#14 | -5.6%#7 | -5.2%#6 | — | 6#1 | — | — |
| PCTTU | $1.8B#7 | — | 239.0x#10 | 212.4x#10 | — | 36.9%#5 | -2171.6%#11 | -2459.1%#9 | -110.7%#8 | — | — | — |
| PCT | $1.2B#8 | — | 154.9x#9 | 137.7x#9 | — | 36.9%#5 | -2171.6%#11 | -2459.1%#9 | -110.7%#8 | — | — | — |
| ASIX | $541M#9 | 55.7x#4 | 0.7x#1 | 0.4x#1 | 0.3%#3 | 11.8%#9 | 3.6%#6 | 6.2%#4 | — | 6#1 | — | 3.2%#3 |
| PCTTW | $307M#10 | — | 41.4x#8 | 36.8x#8 | — | 36.9%#5 | -2171.6%#11 | -2459.1%#9 | -110.7%#8 | — | — | — |
| ALB.PA | — | — | — | — | -4.4%#6 | 56.7%#3 | -7.1%#8 | -5.2%#7 | -2.4%#6 | 6#1 | — | — |
| PCTBP | — | — | — | — | — | 36.9%#5 | -2171.6%#11 | -2459.1%#9 | -110.7%#8 | — | — | — |
| TSEOQ | — | — | — | — | -15.3%#10 | -56.6%#13 | -8.5%#10 | — | — | 2#9 | — | — |
数值来自 SEC 申报与延迟行情;排名仅为该组内的排序位置 —— 描述性数据,不构成评级或建议。 本表构建超时,仅覆盖该组的一部分成员;排名仅相对于已列出的行,稍后会自动补全。 数据构建于 2026-08-02。
数据来自 SEC XBRL 申报与延迟行情 · 排名为组内排序 · 仅供参考 · 非投资建议